Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Andrew Vernon, Philip C. Hopewell et al.|Clinical Infectious Diseases|2016Cited by 1.5k
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Andrew Vernon, Susan E. Dorman et al.|Clinical Infectious Diseases|2016Cited by 321
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis NetworkGiovanni Battista Migliori, José-María García-García, Simon Tiberi et al.|International Journal of Infectious Diseases|2020Cited by 226
Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for EuropeGiovanni Battista Migliori, Masoud Dara, Edward A. Nardell et al.|European Respiratory Journal|2019Cited by 130
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort studyOleksandr Korotych, Askar Yedilbayev, Jay Achar et al.|The Lancet Infectious Diseases|2024Cited by 23